Lux Capital

Lux Capital is a venture capital firm established in 2000 and headquartered in New York, New York. The firm specializes in investments in early-stage and growth companies, focusing on sectors such as biochemistry, material science, electronics, infrastructure, and aerospace. With over $5 billion in assets under management, Lux Capital takes an active role in supporting entrepreneurs, aiming to build successful businesses in high-growth industries. The investment team has a track record of founding more than 20 companies, employing strategies that enhance connectivity, insight, and competitive leadership for its portfolio companies. As a Registered Investment Adviser, Lux Capital is committed to fostering innovation at the intersection of technology and the sciences.

Tuvia Barak

Venture Partner

Peter Hebert

Co-Founder and Managing Partner

Lan Jiang

Investor

Alex Nguyen

Principal

Brandon Reeves

Partner

Segolene Scarborough

CFO

Zack Schildhorn

Partner

Deena Shakir

General Partner

Tess Van Stekelenburg

Partner

Shahin Farshchi

Partner

Past deals in Early Venture Stage

Jericho Security

Series A in 2025
Jericho Security is protect the world from the emerging dangers of generative AI cyberattacks. Jericho Security created proprietary generative AI, cyberGPT, to simulate attacks, create new defenses and educate to prevent serious losses from cyberattacks.

ConductorAI

Series A in 2025
ConductorAI helps the government identify people, policies, and approvals needed within their own agencies to get things done

Kela Technologies

Series A in 2025
Kela Technologies is a secure, open platform that enables the rapid and seamless integration of commercial and military systems in support of Western defense.

Maven AGI

Series A in 2024
Maven AGI is a technology company that focuses on the development of modern artificial intelligence (AI) solutions. Their primary aim is to reimagine the customer support experience by leveraging AI to lower costs, improve speed and quality, and drive efficiency. Their AI solutions are designed to unlock human potential by enabling teams to be more productive and giving them time back to do the work only humans can do. They also offer a range of services including customer acquisition strategy and operational planning. The company has a team size of 50 employees, with roles ranging from product management to sales and marketing.

Privateer

Series A in 2024
Privateer is focused on developing data infrastructure to support the sustainable growth of the emerging space economy. The company utilizes proprietary knowledge graph technology to enhance the collection and processing of information about space objects. This innovation is crucial as orbital traffic increases, allowing space operators to navigate safely and efficiently. By providing reliable data and tools, Privateer aims to contribute to making space safe and accessible for everyone.

Summer Health

Series A in 2024
Summer Health is a provider of pediatric telehealth services designed to simplify access to healthcare for families. The company enables timely communication with board-certified pediatricians through a text-based platform, allowing users to receive expert answers and reliable advice quickly. Summer Health's services include health tracking and personalized healthcare plans, ensuring that patients can obtain necessary care within minutes. By leveraging digital technology, Summer Health aims to enhance the healthcare experience for families navigating health concerns.

Xaira Therapeutics

Venture Round in 2024
Xaira Therapeutics is an integrated biotechnology company focused on revolutionizing drug discovery and development through the application of artificial intelligence. Headquartered in the San Francisco Bay Area, Xaira combines expertise in machine learning, extensive biological and clinical data generation, and robust therapeutic product development. By harnessing advanced AI techniques, the company aims to enhance the understanding of biological processes and improve the effectiveness of therapies. Xaira's approach encompasses all stages of drug discovery, striving to transform how diseases are treated and enabling clients to deliver innovative therapeutic solutions.

Nominal

Series A in 2024
Nominal offers an engineering data infrastructure platform tailored for hardware teams, focusing on the validation of mission-critical systems. The platform integrates various data sources to analyze and visualize critical hardware information, facilitating effective communication between machines and human engineers. By streamlining workflows, Nominal enables engineers to gain essential insights, supporting timely and reliable decision-making in industrial settings.

Formic

Venture Round in 2024
Formic is a robotics company dedicated to enhancing automation in labor-intensive industries such as food and beverage, advanced manufacturing, and consumer packaged goods. The company focuses on making robotic deployments accessible and straightforward, offering manufacturers flexible automation solutions that allow them to pay based on productivity rather than upfront costs. By combining financial innovation with expertise in robotics, Formic enables businesses to scale their manufacturing capabilities quickly and with reduced risk. The company's mission is to democratize access to automation, ensuring that every factory can benefit from the efficiencies provided by advanced robotic systems.

Together AI

Series A in 2024
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.

Armada

Series A in 2023
Armada is a developer of an edge computing platform that aims to enhance connectivity and facilitate real-time data processing for individuals and businesses. The company focuses on closing the digital gap by providing a resilient, secure, and scalable infrastructure, complemented by compatible software components. This integrated approach enables users to efficiently manage and optimize their data through a single control plane, ultimately supporting improved decision-making and the effective use of artificial intelligence tools.

Modal Labs

Series A in 2023
Modal Labs is a technology company that specializes in machine learning software designed to facilitate code execution in the cloud. Its platform allows users to deploy machine learning models, run massively parallel compute jobs, manage task queues, and host web applications. By utilizing containers, Modal's software automates the provisioning of compute instances, hardware accelerators, and cloud storage. This enables data science teams to concentrate on developing their models and applications without the burden of managing intricate infrastructure, thereby enhancing efficiency and performance in cloud-based computing environments.

Kinetic Automation

Series A in 2023
Kinetic Automation is transforming the automotive repair industry by developing an advanced infrastructure that integrates hardware, robotics, software, and artificial intelligence. The company focuses on providing mobility services specifically for electric and autonomous vehicles through its automated repair centers. Utilizing precision technology powered by machine learning, Kinetic aims to deliver rapid, accurate, and predictable maintenance solutions. Its innovative approach positions Kinetic as a key player in the future of automotive servicing, facilitating essential support for electric vehicle owners and enhancing the overall efficiency of vehicle maintenance.

Mendaera

Series A in 2023
Mendaera is a medtech startup that specializes in developing advanced healthcare technologies, with a focus on robotics and diagnostic tools. The company aims to enhance clinical judgment and technical expertise to make high-quality care accessible to all patients across various care facilities. Mendaera's innovative platform, currently in development, combines real-time imaging, robotics, and artificial intelligence to assist physicians in both image acquisition and interpretation. This integration facilitates precise and consistent point-of-care interventions, streamlining the patient journey, accelerating recovery, and reducing overall care costs. By empowering healthcare professionals with these advanced technologies, Mendaera seeks to improve the efficacy and accessibility of medical procedures.

Mythic

Venture Round in 2023
Mythic Inc. is a technology company that designs and develops silicon chips and artificial intelligence processing units (IPUs) for a wide range of applications, from consumer electronics and wearables to autonomous vehicles and robotic drones. Founded in 2012 and headquartered in Redwood City, California, with an additional office in Austin, Texas, Mythic specializes in analog matrix processors that utilize unique compute-in-memory technology. Their products, including the M1076 Analog Matrix Processor and various PCIe and M.2 cards, integrate AI capabilities directly into compact chips, enabling desktop-level processing power in smaller devices. The company emphasizes its expertise in neural networks, processor architecture, and software design to deliver efficient AI solutions while maintaining performance, power efficiency, and accuracy in real-world environments.

Aera Therapeutics

Series A in 2023
Aera Therapeutics is a biotechnology company focused on enhancing the delivery of genetic medicines through its proprietary protein nanoparticle (PNP) platform. This innovative platform utilizes endogenous human proteins to create capsid-like structures that can effectively package and transfer nucleic acid cargo. By addressing the limitations of current delivery technologies, Aera aims to extend the application of genetic medicines across various tissues and disease areas, ultimately benefiting a wider patient population. In addition to its PNP platform, Aera has developed a therapeutic enzyme platform that features novel, compact, and programmable gene-editing enzymes, further advancing its mission to transform the field of genetic medicine.

Paradigm

Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.

Osmo

Venture Round in 2023
Osmo gives computers a sense of smell that improves the health and well-being of human life. Osmo brings together frontier AI and olfactory science to tackle a historic challenge. While they are initially focused on the intricate world of fragrance, their ultimate objective is to enhance the health and well-being of human life through the sense of smell.

Cajal Neuroscience

Series A in 2022
Cajal Neuroscience is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. By integrating human genetics, functional genomics, and advanced microscopy, the company aims to identify novel therapeutic targets. Cajal utilizes a range of cutting-edge technologies, including high-throughput functional genomics and multi-omics approaches, to screen for targets that significantly influence the progression of neurodegenerative diseases. This comprehensive methodology supports the development of precision medicine, ultimately aiding healthcare professionals in treating patients affected by these conditions.

Impulse

Series A in 2022
Impulse is a manufacturer of electric home appliances focused on reducing natural gas consumption and promoting sustainability. The company develops next-generation products that integrate batteries, allowing for energy storage without the need for extensive electrical upgrades. Its flagship product is a high-performance induction stove equipped with a built-in battery, enabling users to enhance their appliances with minimal rewiring. This innovation facilitates home electrification and contributes to lower carbon emissions, providing both residential and commercial owners with a means to create healthier and more efficient living and working environments. Impulse aims to transform the home appliance sector by emphasizing ease of installation, high performance, and environmental responsibility.

Column

Series A in 2022
Column is a public benefit company focused on enhancing the value of public information systems through technology. It offers a user-friendly public notice software platform designed to streamline operations for various clients, including governments, legal services, individuals, and businesses, who are mandated by law to publish notices. The company's platform simplifies the publication process and provides an application programming interface that grants read access to the public information ecosystem. This approach aims to make public information more accessible to the general public, thereby improving transparency and efficiency in the dissemination of essential notices.

Epsilon3

Series A in 2022
Epsilon3 develops advanced software technology aimed at modernizing space missions and complex engineering operations. By creating an industry-standard platform, Epsilon3 provides interactive, real-time synchronized procedures for various programs and missions. This allows satellite operators, space manufacturers, and integrators to access detailed analytics, reports, and dashboards. The software enhances efficiency and user-friendliness, enabling operators to streamline their workflows and save time and resources throughout the entire project lifecycle. Epsilon3's commitment to improving operational software represents a significant advancement in the aerospace sector.

Fruitful

Series A in 2022
Fruitful is a financial wellness platform aimed at empowering individuals to manage their finances more effectively. The platform provides members with personalized financial advice from qualified specialists, hands-on investment management, and access to high-yield savings options. It also simplifies the banking experience by offering tools that integrate various third-party apps, bank accounts, and financial services into a single dashboard. This subscription-based model allows users to benefit from tailored banking services while enhancing their financial understanding and promoting a secure financial future.

Anagenex

Series A in 2022
Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.

LatchBio

Series A in 2022
LatchBio is a company that specializes in developing a bioinformatics platform aimed at supporting cell and gene therapy startups. Established in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, LatchBio provides an open-source machine learning and cloud infrastructure tailored for the biotech sector. Its platform modernizes the computing capabilities available to biotech labs by offering custom workflows, pipelines, and machine learning models that can be utilized across various scales. This infrastructure enables scientists to efficiently create bioinformatic queries without requiring extensive command-line knowledge or dealing with complex setups. By streamlining data integration and processing, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.

Umba

Series A in 2022
Umba is a digital bank based in Nairobi, Kenya, that provides mobile financial services to customers in Kenya and Nigeria. Founded in 2017, Umba offers free bank accounts and a suite of connected financial services, allowing users to manage their finances through a single application. The platform enables customers to apply for, receive, and repay microloans, utilizing machine learning to assess credit eligibility and optimize risk management. By streamlining financial access, Umba aims to empower individuals in emerging markets to take control of their financial well-being.

Hadrian

Series A in 2022
Hadrian is a startup focused on manufacturing precision components for the aerospace and defense industries. It specializes in creating autonomous, software-defined factories that produce critical parts for technology companies involved in building rockets, satellites, jets, and electric vertical takeoff and landing (eVTOL) aircraft. By streamlining the production process and reducing costs, Hadrian enables frontier technology enterprises to efficiently manufacture advanced aerospace systems.

Cloaked

Series A in 2022
Cloaked is a privacy-focused company that empowers individuals to manage their personal data by providing them with unlimited, unique identities. Its platform is designed to enhance privacy protection for online activities and travel, allowing users to access various online services without disclosing sensitive information such as personal emails, phone numbers, or addresses. By enabling users to control how they engage in the digital landscape, Cloaked alleviates the pressure to share personal information both online and in person, fostering a safer and more private online experience.

Alife

Series A in 2022
Alife is a health technology company that focuses on using artificial intelligence to enhance the success rates of pregnancy for individuals undergoing fertility treatments. Founded in 2020 by Paxton Maeder-York and based in San Francisco, California, Alife aims to assist physicians in selecting the healthiest embryos through advanced deep learning and software development. By connecting fertility specialists with patients, the company seeks to improve the overall chances of achieving healthy pregnancies, ultimately supporting its mission of helping people have healthy children.

Creyon Bio

Series A in 2022
Creyon Bio is a pre-clinical stage company reimagining drug development as it should be, using a data-first approach for generating uniquely powerful datasets and developing machine learning models to uncover the engineering principles that make precision oligonucleotide-based medicines possible for patient populations of all sizes.

Neo.Tax

Series A in 2022
Neo.Tax, based in Mountain View, California, offers tax preparation and automation services through its innovative software platform. The company focuses on simplifying the often complex process of applying for the Research and Development (R&D) tax credit, especially in light of recent tax law changes regarding R&D capitalization. By leveraging machine learning algorithms, Neo.Tax automates the collection and organization of data from various sources, including emails, documents, and financial systems, which streamlines the tax filing process. Their platform is designed to assist both early-stage startups and larger public companies, ensuring they are audit-ready and capable of optimizing their tax liability. Through its solutions, Neo.Tax aims to alleviate common challenges faced by finance teams in accurately documenting activities and expenses related to tax credits.

Parallel Markets

Series A in 2022
Parallel Markets Inc. is a New York-based company founded in 2018 that specializes in identity verification and accreditation for financial platforms. The company operates an online platform that simplifies the onboarding and verification process for both investors and investment platforms. It enables investors to authenticate and share their credentials across various platforms with a single click, streamlining the way individuals and entities assert their qualifications. Parallel Markets provides a comprehensive suite of identity products, facilitating efficient investor verification and allowing for easier engagement in the investment process. By focusing on user-friendly solutions, the company aims to enhance the overall experience of onboarding for its partners and their clients.

Gandeeva Therapeutics

Series A in 2022
Gandeeva Therapeutics is a precision biotechnology company focused on developing innovative therapeutics by leveraging cryogenic electron microscopy and machine learning to target key protein-protein interactions. The company's structure-guided drug discovery platform includes target prediction and validation, hit identification through virtual and fragment library screening, and lead optimization. Gandeeva has established a strong preclinical oncology pipeline aimed at addressing challenging cancers with unique protein interaction modulators, including interfacial glues and allosteric inhibitors. Headquartered in the Greater Vancouver area, Canada, Gandeeva is dedicated to enhancing the drug discovery process and reducing the risk of late-stage clinical failures.

Formic

Series A in 2022
Formic is a robotics company dedicated to enhancing automation in labor-intensive industries such as food and beverage, advanced manufacturing, and consumer packaged goods. The company focuses on making robotic deployments accessible and straightforward, offering manufacturers flexible automation solutions that allow them to pay based on productivity rather than upfront costs. By combining financial innovation with expertise in robotics, Formic enables businesses to scale their manufacturing capabilities quickly and with reduced risk. The company's mission is to democratize access to automation, ensuring that every factory can benefit from the efficiencies provided by advanced robotic systems.

Gameto

Series A in 2022
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.

Waymark

Series A in 2022
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.

Nomic

Series A in 2021
Nomic is a bioengineering company focused on making the human proteome as accessible as the human genome. The company is developing the nELISA, a next-generation platform for measuring proteins at high throughput and scale. Nomic provides scientists with protein profiling solutions, allowing them to determine the scope and scale of their experiments. Their platform features cost-effective measurement of protein data and integrates smoothly with industry-standard cytometers for high-throughput analysis. Additionally, Nomic's technology enables the development of custom protein panels, leveraging nanotechnology to use DNA as a versatile linker to address issues of cross-reactivity in protein measurement.

Shiru

Series A in 2021
Shiru, Inc. is a food technology company based in Oakland, California, established in 2019. The company specializes in developing and producing edible proteins aimed at replacing dairy products and eggs in the food industry. By leveraging artificial intelligence and computational design, Shiru creates enhanced proteins that contribute to sustainable food production. The company's focus on using bioinformatics and precision biology allows it to discover novel natural proteins, thereby enabling clients to replace harmful ingredients with healthier alternatives.

Kingdom Supercultures

Series A in 2021
Kingdom Supercultures specializes in the development and production of microbial cultures that assist food manufacturers in creating innovative food products. Founded in 2019 and based in Brooklyn, New York, the company offers Koji, a traditional Japanese ingredient used in various fermented foods and beverages. Their technology utilizes an extensive biobank of Generally Recognized As Safe (GRAS) microbial strains and employs automated systems to characterize and assemble these strains into new combinations. This enables the production of plant-based foods that replicate dairy flavors, low-alcohol beverages with rich taste, and effective natural preservatives. Kingdom Supercultures collaborates with clients across multiple sectors, including food, beverage, personal care, and beauty, focusing on enhancing the health and sustainability of food offerings.

Copia

Series A in 2021
Copia specializes in providing advanced tools for industrial automation, focusing on enhancing the efficiency and effectiveness of control engineers. The company's flagship product offers Git-based source control specifically designed for programmable logic controller (PLC) programming, which enables robust version control, improved change visibility, and seamless collaboration. By streamlining the commissioning and operation of industrial machinery, Copia's solutions foster faster project delivery and enhanced operational uptime. With a commitment to transforming the industrial landscape, Copia's tools also support quality control, streamlined production processes, and proactive crisis management, thereby equipping clients with the necessary resources to navigate the complexities of modern automation.

A-Alpha Bio

Series A in 2021
A-Alpha Bio, Inc. is a biotechnology company based in Seattle, Washington, established in 2017. The company specializes in synthetic biology, offering a platform known as AlphaSeq, which assists pharmaceutical companies in the development of drugs that interact with multiple targets. A-Alpha Bio provides cell-based tools for high-throughput and quantitative measurements of protein interactions, facilitating target discovery, library screening, and preclinical drug characterization. Its proprietary technology enables the mapping of protein-protein interactions at a large scale, allowing for the identification and quantification of interactions among thousands of protein pairs simultaneously. By delivering detailed maps of these interactions, A-Alpha Bio helps researchers identify potential drug targets and understand disease mechanisms, thereby streamlining the therapeutic discovery process and improving the efficiency of drug development. The company comprises a team of experts in synthetic biology, structural biology, and next-generation sequencing, focused on overcoming challenges in the drug development pipeline.

Atavistik Bio

Series A in 2021
Atavistik Bio is a pre-clinical biotechnology company dedicated to discovering and developing innovative therapies for metabolic diseases and cancer. The company focuses on identifying metabolite-protein interactions and harnessing nature's allosteric control mechanisms to create first-in-class drug candidates. By applying its platform to genetically validated targets, Atavistik Bio aims to advance novel treatments that address significant medical needs in these areas.

Ahana

Series A in 2021
Ahana, founded in 2020 and based in San Mateo, California, specializes in developing ad hoc analytics solutions built on PrestoDB. The company aims to simplify interactive analytics for organizations of various sizes, providing a platform that facilitates efficient data analysis. Recognizing the widespread adoption of Presto in major internet companies, Ahana focuses on bringing these capabilities to a broader audience while actively promoting and supporting the Presto community. Through its offerings, Ahana seeks to enhance the accessibility and usability of ad hoc analytics across diverse sectors.

HiHello

Series A in 2021
HiHello, Inc. is a software company based in Palo Alto, California, that specializes in developing innovative solutions for contact management and networking. Founded in 2018, HiHello offers a mobile application that enables users to share their contact information with clients and friends through various methods, such as codes, text messages, or emails. The platform allows individuals to create personalized digital business cards, scan physical cards, and maintain an up-to-date address book, facilitating connections that can enhance professional relationships. By streamlining the process of sharing and managing contact details, HiHello aims to help users optimize their business interactions and foster mutually beneficial connections.

Varda

Series A in 2021
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.

Enveda Biosciences

Series A in 2021
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

System

Series A in 2021
System Inc. is a Public Benefit Corporation that specializes in developing software aimed at helping individuals and organizations understand and address complex systems. The company's technology is designed to organize knowledge and data from disparate sources, allowing users to uncover insights based on statistical relationships. By enabling professionals to see and relate information more effectively, System's software facilitates the integration of data across various platforms, empowering users to solve intricate problems and make informed decisions.

Dyno Therapeutics

Series A in 2021
Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative adeno-associated virus (AAV) vectors for gene therapy applications. Founded in 2018, the company employs an artificial intelligence-powered platform that integrates next-generation DNA synthesis, high-throughput sequencing, and machine learning. This advanced approach allows Dyno Therapeutics to design and optimize cell-targeting capsids, which are crucial for the effective and safe delivery of gene therapies. By leveraging its technology, the company aims to provide medical researchers with novel AAV vectors that enhance the efficacy of in vivo therapeutic solutions.

Eikon Therapeutics

Series A in 2021
Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By integrating biology, engineering, and chemistry, Eikon Therapeutics aims to enhance the understanding of cellular processes and improve drug discovery efficiency. Its proprietary platforms allow for the sensitive identification of compound-protein interactions, enabling the direct measurement of how chemical compounds affect individual proteins in live cells. This novel approach seeks to unlock new therapeutic opportunities and expand the company's pipeline of potential medications.

Pawp

Series A in 2021
Pawp, Inc. is a digital health clinic and telehealth platform focused on pet care, connecting pet owners with licensed veterinary professionals. Founded in 2020 and based in New York, the platform offers users unlimited 24/7 access to veterinarians, allowing for timely consultations that can often replace unnecessary in-person visits. Additionally, Pawp provides a yearly pet emergency fund of $3,000, serving as a financial safety net for unexpected veterinary expenses. By facilitating these services, Pawp aims to empower pet owners to make informed health decisions for their pets while managing costs effectively.

Multiply Labs

Series A in 2021
Multiply Labs specializes in the production of personalized pharmaceutical capsules that cater to the unique needs of individual patients. The company leverages a combination of pharmaceutical science and advanced robotics technology to create these tailor-made capsules. Its innovative approach includes operating a state-of-the-art robotic manufacturing facility, which allows for the efficient production of individualized drugs at a reduced cost. Multiply Labs stands out as a pioneer in the industry, being the first to introduce 3D printed capsules, thereby transforming how medications are customized to meet the specific metabolic requirements of patients.

ZEDEDA

Series A in 2021
ZEDEDA, Inc. specializes in edge virtualization software that provides visibility, control, and security for IoT edge gateways, applications, and networks. Founded in 2016 and headquartered in Santa Clara, California, with additional offices in Bengaluru and Pune, the company offers a cloud-native platform that enables organizations to monitor, visualize, and secure real-time edge applications. Its Edge Quick Connect for Azure IoT Edge is a Software as a Service (SaaS) solution that facilitates the management and protection of IoT deployments through virtualization. ZEDEDA's offerings support various applications, including predictive analytics in renewable energy, digital transformation in the oil and gas sector, and industrial automation, allowing clients to maintain control over their edge data without being locked into specific vendors or solutions.

Plexium

Series A in 2021
Plexium, Inc. is a biotechnology company based in San Diego, California, that specializes in developing targeted protein degradation therapies aimed at treating cancer and neurodegenerative diseases. Founded in 2017, Plexium utilizes a platform that identifies small molecules capable of modulating E3 ligases, which play a crucial role in protein degradation. This platform includes the DELPhe screening technology, designed for high-content readouts from cell-based assays. By harnessing E3 ligases, Plexium's approach enables selective targeting of various cancers, including small cell lung and breast tumors. The company's innovative research extends beyond existing therapies, exploring new drug-like protein degraders and molecular glues to enhance treatment options for cancer and inflammatory diseases.

Vosbor

Series A in 2021
Vosbor is a global digital marketplace that facilitates the trade of bulk agricultural commodities, including corn, wheat, soybeans, and palm oil, among others. Founded in 2019 and headquartered in Amsterdam, with additional offices in Singapore, Vosbor offers a secure and transparent environment for connecting buyers and sellers. Its platform utilizes blockchain technology to enhance the management of international trade logistics and settlement. By allowing users to reconcile trade data and securely share documents through smart contracts, Vosbor enables clients to efficiently execute their trade, finance, and shipping operations.

Runway

Series A in 2020
Runway is an applied AI research company focused on transforming the fields of art, entertainment, and human creativity through innovative technology. The company offers an AI-powered video editing platform designed for professionals, providing tools that utilize original image and video creation techniques. These tools facilitate synthetic manipulation and editing by allowing users to edit and create videos using text-based commands. As a result, Runway enables artists, designers, and filmmakers to engage with a user-friendly visual interface, streamlining their creative processes and enhancing their projects.

LabGenius

Series A in 2020
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.

Auransa

Series A in 2020
Auransa Inc., founded in 2014 and based in Palo Alto, California, is a clinical stage drug development company focused on creating innovative treatments for challenging diseases, including cancer, autoimmune, and neurological disorders. Utilizing a proprietary artificial intelligence platform, Auransa analyzes extensive genomic data from human disease tissues to study molecular subtypes of diseases. This approach allows the company to predict potential drug compounds and identify targets tailored for specific patient populations. Currently, Auransa's internal drug pipeline features a first-in-class investigational new drug for cancer that is undergoing clinical trials. The company actively collaborates with various partners in the biopharma sector to advance its drug development efforts.

Statespace

Series A in 2020
StateSpace provides performance analytics and a suite of tools for casual gamers and esports athletes to maximize their potential. It uses cognitive science and artificial intelligence to revolutionize the way humans improve. Leveraging expertise as neuroscientists, data scientists, video game developers, and computer visionaries, the products bring much needed standardized performance analytics to train.It was founded in 2017 and is headquartered in New York, New York.

Mos

Series A in 2020
Mos is a financial services platform dedicated to assisting students in navigating the complexities of financing their education. It provides checking accounts, debit cards, and access to financial aid advisors, all designed to simplify the financial aid process. The platform offers comprehensive guidance to help students identify and secure scholarships and other financial resources, thereby reducing the costs associated with higher education. By focusing on removing financial barriers, Mos aims to empower students to achieve their academic goals without the burden of unnecessary fees or uncertainty in funding options.

Braid Health

Series A in 2020
Braid Health, Inc., founded in 2018 and headquartered in San Francisco, California, specializes in developing artificial intelligence-driven diagnostic tools for radiology. The company offers an AI-powered diagnostic collaboration platform that enhances the speed, quality, and workflow of radiologists and healthcare providers. By integrating AI diagnostics with the expertise of board-certified radiologists, Braid Health supports real-time quality assurance and facilitates seamless integration with Electronic Health Records (EHR). This innovative approach allows healthcare professionals to deliver accurate diagnoses efficiently, improving overall patient care and access to medical imaging services.

Tecton

Series A in 2020
Tecton offers an enterprise-ready feature store that addresses the unique data requirements of machine learning. By providing a robust data platform, Tecton enables machine learning teams to efficiently build, serve, and scale features for production use. The platform allows users to construct features from various data sources, including batch, streaming, and real-time data, facilitating the sharing, reuse, and deployment of models. This capability empowers data scientists and organizations to automate decisions at high speed, enhance customer experiences, and transform business processes. Tecton's focus on optimizing the data layer for machine learning aims to help companies develop superior models more rapidly, driving significant business outcomes.

Mahana Therapeutics

Series A in 2020
Mahana Therapeutics, Inc. is a healthcare company focused on developing digital treatments for individuals with gastrointestinal diseases, particularly irritable bowel syndrome (IBS). The company offers a clinically validated application called Parallel, which provides a minimal-contact digital program aimed at improving the quality of life for patients suffering from IBS. Founded in 2018 and headquartered in San Francisco, California, Mahana Therapeutics also has an office in London, United Kingdom. The company's solutions are designed to deliver both physical and psychological support, ensuring that patients receive clinically proven assistance to help them manage their chronic health conditions effectively.

AllStripes

Series A in 2020
AllStripes is a healthcare technology company focused on accelerating the development of treatments for rare diseases. The company has created a platform that produces regulatory-ready evidence to support rare disease research and drug development. This platform operates as a two-sided network where patients with rare diseases and advocacy groups contribute valuable information, while life science companies utilize this data to identify new drug candidates. Additionally, AllStripes offers a patient application that allows individuals to engage in treatment research online and leverage their own medical data, fostering a collaborative environment aimed at advancing medical research for rare conditions.

Looking Glass

Series A in 2020
Looking Glass Factory is a company focused on developing holographic technology, primarily through its flagship product, the Looking Glass, which is the first desktop holographic display designed for 3D creators. Founded in 2015 and based in Brooklyn, New York, with a subsidiary in Hong Kong, the company aims to make 3D creation accessible without the need for virtual reality or augmented reality headsets. Looking Glass Factory also offers a web-based holographic sharing platform that utilizes light field rendering software, allowing artists, designers, developers, filmmakers, and photographers to engage with 3D content in an innovative manner.

Rivet

Series A in 2020
Rivet is fixing the adversarial relationship between healthcare providers and payers, arming providers with more sophistication and productivity to improve financial transparency and operational efficiency.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is a technology and clinical services organization that focuses on enhancing the connection between caregivers and the broader care team. The company provides 24/7 telehealth support for caregivers and care recipients, particularly targeting high-need, frail senior populations. By partnering with home care agencies, health plans, and healthcare providers, Vesta Healthcare develops value-based population health programs that prioritize clinical quality, improved health outcomes, and personalized engagement. Originally established as Hometeam Technologies, Inc. in 2008, the company rebranded to Vesta Healthcare in January 2020 and is headquartered in New York, New York.

SkySelect

Series A in 2020
SkySelect is a digital procurement platform that specializes in the aircraft parts industry, which is valued at $100 billion. The company provides a comprehensive solution for airlines to streamline the purchasing and fulfillment processes of high-quality aircraft parts. By automating sourcing from a diverse network of suppliers, SkySelect facilitates efficient management of quote workflows and tracks the follow-up and delivery of spare parts. This technology enables maintenance leaders in the aviation sector to enhance operational efficiency and ensure timely service, thereby fostering secure and swift transactions between buyers and suppliers.

Lumafield

Series A in 2020
Lumafield specializes in industrial computed tomography (CT) solutions, providing advanced non-destructive testing and inspection tools for engineers. The company's flagship product, the Neptune X-ray CT scanner, offers detailed imaging that allows engineers to analyze internal structures and identify defects in various materials. Complementing this hardware is the Voyager software platform, which facilitates cloud-based, AI-powered analysis, enabling automated inspections and collaborative efforts among teams. Additionally, Lumafield's Triton system is designed for high-speed scanning, catering to the needs of high-volume manufacturing environments. The company serves diverse industries, including aerospace, automotive, electronics, and medical devices, aiming to enhance product quality and reliability throughout the product development process.

Hugging Face

Series A in 2019
Hugging Face, Inc. is an open-source platform provider specializing in machine learning technologies, founded in 2016 and headquartered in New York City. The company focuses on democratizing machine learning by facilitating collaboration on models, datasets, and applications within a community-driven environment. Hugging Face offers tools and services that allow users to create, discover, and collaborate on machine learning projects. In addition to its community platform, the company provides paid computing and enterprise solutions aimed at accelerating development processes. Through its commitment to open-source practices, Hugging Face supports users in advancing the field of machine learning.

Chronosphere

Series A in 2019
Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Fiddler AI

Venture Round in 2019
Fiddler is a pioneer in enterprise Model Performance Management. Data Science, MLOps, and LOB teams use Fiddler to monitor, explain, analyze, and improve their models and build trust into AI. The unified environment provides a common language, centralized controls, and actionable insights to operationalize ML/AI with trust. It addresses the unique challenges of building in-house stable and secure MLOps systems at scale. Unlike observability solutions, Fiddler seamlessly integrates deep XAI and analytics to help you grow into advanced capabilities over time and build a framework for responsible AI practices. F500 organizations use Fiddler across training and production models to accelerate AI time-to-value and scale and increase revenue by connecting predictions to business context (or providing visibility into model performance and behavior).

LabGenius

Series A in 2019
LabGenius Ltd is a biopharmaceutical company based in London that focuses on discovering new biological molecules through the integration of artificial intelligence, automation, and synthetic DNA. Founded in 2012, the company has developed a robotic platform known as EVA, which acts as a robot scientist capable of designing, conducting, and learning from its own experiments. LabGenius specializes in developing next-generation protein therapeutics aimed at addressing unmet medical needs, including conditions like Inflammatory Bowel Disease. Their innovative approach utilizes advanced machine learning and synthetic biology to engineer the properties of protein drugs, enhancing attributes such as protease stability and tissue penetration. This technology enables the efficient creation of protein therapeutics, providing physicians with access to cutting-edge treatments developed through robotic automation.

Variant Bio

Series A in 2019
Variant Bio Inc. is a biotechnology company based in Seattle, Washington, that focuses on developing therapeutics through the study of human genetic diversity. Founded in 2018, the company identifies individuals and populations that exhibit extreme traits of medical significance, utilizing advanced sequencing technologies and analytic methods to uncover the genes and pathways associated with these traits. By leveraging insights from genetic research, Variant Bio aims to discover new therapeutic targets for conditions such as neurodegenerative, autoimmune, and cardiometabolic diseases. The company's innovative approach combines statistical genetics and machine learning, enhancing the potential for genomic drug discovery to address unmet medical needs.

Fiddler AI

Series A in 2019
Fiddler is a pioneer in enterprise Model Performance Management. Data Science, MLOps, and LOB teams use Fiddler to monitor, explain, analyze, and improve their models and build trust into AI. The unified environment provides a common language, centralized controls, and actionable insights to operationalize ML/AI with trust. It addresses the unique challenges of building in-house stable and secure MLOps systems at scale. Unlike observability solutions, Fiddler seamlessly integrates deep XAI and analytics to help you grow into advanced capabilities over time and build a framework for responsible AI practices. F500 organizations use Fiddler across training and production models to accelerate AI time-to-value and scale and increase revenue by connecting predictions to business context (or providing visibility into model performance and behavior).

Caper

Series A in 2019
Caper (caper.ai) focuses on compacting Amazon-Go's technology (image recognition, sensor fusion and artificial intelligence) into a smart shopping cart, allowing each shopper to throw her groceries into the cart and self-checkout without cashiers. The technology is looking to fundamentally transform physical retail and rapidly scale into existing grocery stores.

Yonder

Series A in 2019
Yonder LLC, founded in 2017 and based in Austin, Texas, develops an application designed to help brands contextualize online information. The company aims to enhance the understanding of digital content by adding cultural context to information as it circulates on the internet. Yonder's mission is rooted in the belief that the internet should democratize information flow and combat the issues of misinformation, fake accounts, and disinformation that arise when content is presented without context. By addressing these challenges, Yonder seeks to foster a more trustworthy and open digital environment.

Lightform

Series A in 2019
Lightform, Inc. is a computer vision and hardware company based in San Francisco, California, specializing in projected augmented reality. Founded in 2014, the company develops innovative solutions that enable users to create and project animated content onto various scenes. Their offerings include sound-reactive projectors, projector kits, and a desktop application that simplifies the projection mapping workflow, allowing for seamless control and content updates via laptop or smartphone. Lightform's technology incorporates 3D scanning capabilities, enabling the capture of complex scenes and automatic alignment adjustments, which enhance the integration of real objects with projected imagery. By streamlining the creation and projection process, Lightform empowers users to transform spaces with dynamic visual effects and ambient interfaces.

Veo Robotics

Series A in 2019
Veo Robotics is transforming manufacturing with products that incorporate advanced computer vision, 3D sensing, and AI. Their first product lets high-performance industrial robots work collaboratively with people to enable much more flexible, productive, and efficient manufacturing workcells.

ZEDEDA

Series A in 2019
ZEDEDA, Inc. specializes in edge virtualization software that provides visibility, control, and security for IoT edge gateways, applications, and networks. Founded in 2016 and headquartered in Santa Clara, California, with additional offices in Bengaluru and Pune, the company offers a cloud-native platform that enables organizations to monitor, visualize, and secure real-time edge applications. Its Edge Quick Connect for Azure IoT Edge is a Software as a Service (SaaS) solution that facilitates the management and protection of IoT deployments through virtualization. ZEDEDA's offerings support various applications, including predictive analytics in renewable energy, digital transformation in the oil and gas sector, and industrial automation, allowing clients to maintain control over their edge data without being locked into specific vendors or solutions.

Bright Machines

Series A in 2018
Bright Machines, Inc. is a manufacturing company founded in 2018 and based in San Francisco, California, with additional offices in Tel Aviv, China, and Mexico. The company specializes in creating robotic arms and cells for micro factories, focusing on the assembly and inspection of electronic products. It aims to reduce manual labor in manufacturing by integrating advanced robotics with a software-defined manufacturing platform. This platform leverages artificial intelligence, machine learning, and production data to enhance automation processes, resulting in robots that are adaptable and equipped with sensor technology and computer vision. Bright Machines enables its clients to innovate rapidly and achieve better production yields at lower costs, meeting the evolving demands of the manufacturing sector.

Aeva

Series A in 2018
Aeva is a machine vision company that specializes in developing advanced optical-based sensors, particularly in the field of lidar technology, which is essential for autonomous vehicles. Founded in 2016 and headquartered in Mountain View, California, Aeva integrates vision, depth, and motion sensing into a single product that delivers superior performance regarding range, resolution, and velocity measurement under various weather conditions. Its proprietary Frequency Modulated Continuous Wave (FMCW) technology enables the creation of a 4D LiDAR-on-chip, which has applications beyond automated driving, including consumer electronics, health, industrial automation, and security. Aeva operates primarily in North America, EMEA, and Asia, with the majority of its revenue generated from the North American market.

Applied Intuition

Series A in 2018
Applied Intuition, Inc. is a software company established in 2017 and headquartered in Sunnyvale, California, with additional offices in Silicon Valley and Detroit, Michigan. The company specializes in providing software infrastructure that supports the safe development, testing, and deployment of autonomous vehicles at scale. Its product suite emphasizes advanced simulation and analytics, offering automotive industries the tools needed to comprehensively test their autonomous vehicle systems. By delivering sophisticated infrastructure tailored for scalability, Applied Intuition enables faster and more efficient development processes for companies in the autonomous vehicle sector.

Yonder

Series A in 2018
Yonder LLC, founded in 2017 and based in Austin, Texas, develops an application designed to help brands contextualize online information. The company aims to enhance the understanding of digital content by adding cultural context to information as it circulates on the internet. Yonder's mission is rooted in the belief that the internet should democratize information flow and combat the issues of misinformation, fake accounts, and disinformation that arise when content is presented without context. By addressing these challenges, Yonder seeks to foster a more trustworthy and open digital environment.

Oasis Labs

Series A in 2018
Oasis Labs, Inc. is a company that operates a blockchain platform focused on scalable and privacy-preserving smart contracts. Founded in 2018 and headquartered in San Francisco, California, Oasis Labs provides a privacy-first cloud computing solution that supports the development of decentralized applications. The platform enables the creation of smart contract applications that prioritize privacy while maintaining high performance and scalability. By addressing challenges related to data management and security, Oasis Labs aims to facilitate the adoption of blockchain technology in real-world applications and empower businesses to leverage decentralized trust without compromising privacy.

Novel Effect

Series A in 2018
Novel Effect is a Seattle-based company that specializes in voice-driven media and entertainment. Its primary offering is a voice interactive storytelling application that enhances the reading experience by synchronizing theme music and sound effects with voice recognition technology. This innovative application provides voice-activated companion audio that activates as children read, creating immersive and interactive experiences. By blending physical and digital worlds, Novel Effect aims to foster learning and engagement between children and parents in a manner that is both supportive and non-distracting. The company's focus is on enriching storytelling through technology, making it easier for families to enjoy books, videos, and games together.

Arraiy

Series A in 2018
Arraiy, Inc. is a company based in Palo Alto, California, focused on developing an AI-driven production platform for the motion picture and television industry. Founded in 2016 and formerly known as opencv.ai, Arraiy utilizes computer vision and machine learning to enhance the filmmaking process. The company collaborates with major studios, industry veterans, and award-winning artists to innovate visual storytelling and integrate real and virtual worlds seamlessly. Through its platform, Arraiy aims to empower creators with greater creative freedom and redefine the standards of visual content production. As of July 2020, Arraiy operates as a subsidiary of Matterport, Inc.

Senti Bio

Series A in 2018
Senti Biosciences is a clinical-stage biotechnology company specializing in synthetic biology and gene circuit engineering for therapeutic purposes. The company employs its Gene Circuits platform to develop innovative therapies that enhance precision in targeting cancer cells while avoiding damage to healthy cells. Senti Bio's approach involves the use of allogeneic chimeric antigen receptor natural killer (CAR-NK) cells that incorporate its gene circuit technologies, aimed at addressing various oncology indications. Among its product candidates are SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to selectively eliminate cancer cells without harming healthy bone marrow, and SENTI-301A, which targets hepatocellular carcinoma. Senti Biosciences aims to provide effective treatment options for difficult-to-treat diseases through advanced cell and gene therapies.

Pager

Series A in 2018
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.

Primer

Series A in 2017
Primer is an internet company that specializes in utilizing artificial intelligence to analyze extensive text data. By employing machine learning and natural language processing, Primer's platform automates the examination of large datasets, allowing businesses to efficiently parse and collate documents in multiple languages. This technology enables users to uncover insights and generate reports that are comparable to those produced by human analysts. Through its innovative approach, Primer aims to help organizations bridge the intelligence gap and enhance their understanding of complex information, thus facilitating informed decision-making and fostering the ability to respond to emerging trends.

Veo Robotics

Series A in 2017
Veo Robotics is transforming manufacturing with products that incorporate advanced computer vision, 3D sensing, and AI. Their first product lets high-performance industrial robots work collaboratively with people to enable much more flexible, productive, and efficient manufacturing workcells.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.